AMAG Pharmaceuticals RPE
Was ist das RPE von AMAG Pharmaceuticals?
RPE von AMAG Pharmaceuticals, Inc. ist $742.150k
Was ist die Definition von RPE?
Umsatz pro Mitarbeiter (RPE) ist der Umsatz geteilt durch die Anzahl der Mitarbeiter einer Organisation.
RPE von Unternehmen in Health Care Sektor auf NASDAQ im Vergleich zu AMAG Pharmaceuticals
Was macht AMAG Pharmaceuticals?
AMAG Pharmaceuticals, Inc. is a biopharmaceutical company. It focuses on the manufacture, development, and commercialization of a therapeutic iron compound to treat iron deficiency anemia. The firm focuses on the development and commercialization of Feraheme injection for intravenous use to treat iron deficiency anemia. It manufactures, develops, and commercializes products derived from its proprietary technology for use in treating human diseases. Its products include Intrarosa, Vyleesi, Makena, CBR, Feraheme, and MuGard. The company was founded on November 9, 1981 and is headquartered in Waltham, MA.
Unternehmen mit rpe ähnlich AMAG Pharmaceuticals
- LendingTree hat RPE von $740.030k
- Satin Creditcare Network hat RPE von ₨740.480k
- Mediawan SA hat RPE von €741.530k
- Mediawan SA hat RPE von €741.530k
- Hexion hat RPE von $741.795k
- Hing Lee (HK) hat RPE von HKD$742.125k
- AMAG Pharmaceuticals hat RPE von $742.150k
- Viasat hat RPE von $742.175k
- Albertsons Companies hat RPE von $742.282k
- BLS International Services hat RPE von ₨742.466k
- Vertiv Co hat RPE von $742.487k
- Prag Bosimi Synthetics hat RPE von ₨743.089k
- China Trustful hat RPE von HKD$743.235k